FIELD: medicine.
SUBSTANCE: treating and/or preventing overweight and/or obesity related disorders, including type II diabetes mellitus are/is ensured by using a pharmaceutical composition containing metformin and its salts and sibutramine and its salts as ingredients in the following daily dose: sibutramine and its salts of 10 or 15 mg, metformin and its salts of 850 or 1700 mg, microcrystalline cellulose of 158.5 or 153.5 mg. There are also presented: usage and a method of treating and/or preventing the overweight and/or obesity related disorders.
EFFECT: group of inventions possess a synergetic effect, which manifests in the higher effect when used as the ingredients of the combination of metformin and sibutramine.
6 cl, 3 tbl, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| PHARMACEUTICAL COMBINATION FOR TREATING AND/OR PREVENTING DISORDERS RELATED TO OVERWEIGHT AND/OR OBESITY, AND BASED METHOD OF TREATING | 2014 |
|
RU2552926C1 |
| PHARMACEUTICAL COMPOSITION FOR TREATING AND/OR PREVENTING OBESITY RELATED DISORDERS, AND METHOD OF TREATING AND/OR PREVENTING OBESITY RELATED DISORDERS | 2013 |
|
RU2561583C2 |
| METHOD FOR TREATING METABOLISM DISORDERS MAINLY DIABETES CASES AND DISEASES OR STATES RELATED TO DIABETES | 2000 |
|
RU2280447C2 |
| COMPOSITIONS FOR OBESITY TREATING AND PREVENTING | 2013 |
|
RU2646459C2 |
| PHARMACEUTICAL COMBINATION AND COMPOSITION FOR TREATING OBESITY AND USE THEREOF | 2011 |
|
RU2608928C2 |
| METHOD OF TREATING OBESITY AND ACCOMPANYING METABOLIC DISORDERS AND MEDICATION FOR TREATING OBESITY AND ACCOMPANYING METABOLIC DISORDERS | 2010 |
|
RU2552221C2 |
| PHARMACEUTICAL COMPOSITION FOR TREATING TYPE 2 DIABETES | 2010 |
|
RU2533560C2 |
| METHOD FOR COMPLEX TREATMENT OF METABOLIC SYNDROME | 2015 |
|
RU2616125C1 |
| COMPOSITIONS OF PILL WITH IMMEDIATE RELEASE | 2010 |
|
RU2558798C2 |
| COMBINATION FOR TREATMENT OF DIABETES AND COMPLICATIONS THEREOF | 2011 |
|
RU2451506C1 |
